Dr. Lauren Colbert's lab focuses on understanding the role of specific bacteria, particularly Lactobacillus iners, in cervical cancer. The lab investigates how these bacteria influence cancer cell behavior and patient outcomes, aiming to develop new therapies that target the tumor microbiome. This research is especially important for improving treatment options for underserved populations affected by cervical cancer.

Dr. Emil Schueler's research lab focuses on improving cancer treatment through innovative radiation therapies. By investigating ultra-high dose rate radiotherapy, also known as FLASH radiotherapy, the lab aims to enhance tumor control while minimizing damage to surrounding healthy tissues. This work could transform standard radiation therapy, making it safer and more effective for cancer patients.

Dr. Tao Wang's lab focuses on using machine learning to analyze complex biological data, specifically to predict interactions between antigens and antibodies. Their research aims to enhance our understanding of the immune system, contributing to the development of new diagnostic tools and therapeutic antibodies for autoimmune diseases. By combining advanced sequencing technologies and deep learning models, the lab addresses critical challenges in immunology and bioinformatics.

Dr. Jia Wu's lab focuses on improving treatments for early-stage non-small cell lung cancer (NSCLC) using immunotherapy. They are researching how imaging can help identify patients who will benefit most from neoadjuvant immunotherapy before surgery. By developing new imaging biomarkers, the lab aims to enhance the effectiveness of cancer treatments and provide personalized medicine strategies for lung cancer patients.

Dihua Yu's lab focuses on understanding brain metastasis, a serious complication for many cancer patients. The research examines how brain cancer cells interact with brain immune cells to improve treatment strategies. By studying these interactions, the lab aims to develop new therapies that can enhance immune responses and potentially improve survival rates for patients with brain metastases.